Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bed Bath & Beyond's gloomy sales indicate tough turnaround ahead

Published 02/12/2020, 09:37 AM
Updated 02/12/2020, 09:40 AM
© Reuters.  Bed Bath & Beyond's gloomy sales indicate tough turnaround ahead

(Reuters) - Shares of Bed Bath & Beyond Inc (O:BBBY) were on pace for their worst day ever on Wednesday, as disappointing sales numbers raised concerns on Wall Street that the retailer's turnaround would take longer and be much tougher than anticipated.

Analysts were hoping the home furnishing chain's new Chief Executive Officer Mark Tritton to quickly overhaul the business after almost three years of falling same-store sales through divestitures, cost cuts and a revamp of merchandise.

But after Bed Bath & Beyond's Tuesday announcement of a 5.4% drop in same-store sales from the first two months of its fourth quarter due to increased promotions and falling store traffic, Wall Street dimmed its expectations.

"Tritton has a more difficult job ahead than we anticipated and more aggressive changes are needed. We are disappointed with the large step back in the business," analysts at Telsey advisory group wrote in a note.

Telsey said consumers were not responding well to Bed Bath & Beyond's products and pricing, and lowered its price target on the company's stock by $3 to $15. At least four other brokerages cut their price targets to as low as $10.

Bed Bath & Beyond's warning of a torrid final quarter comes just a little over a month after it withdrew its forecast for fiscal 2019.

"We are experiencing short-term pain in our efforts to stabilize the business, including the pressures of store traffic trends coupled with our own executional challenges," Tritton, a former Target Corp (N:TGT) executive, said on Tuesday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Only five out of 18 Wall Street brokerages rate Bed Bath & Beyond's stock "buy" or higher. Ten rate it "hold" and 3 "sell".

The unusual mid-quarter sales announcement also led to a plunge in earnings expectations with Refinitiv's fourth quarter SmartEstimate falling to 20 cents per share on Wednesday, compared with $1.05 per share before Tuesday.

"Looking ahead, competition remains intense from both online and physical retailers, and it will take significant work to reposition the business to remain viable," KeyBanc Capital Markets analyst Bradley Thomas said.

Shares of the company fell 24.4% to $11.22 in premarket trading.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.